Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/2010
12/09/2010US20100311749 4-benzoyl-1-substituted-piperazin-2-one derivatives as p2x7 modulators
12/09/2010US20100311745 1,3-dihydroisoindole derivatives
12/09/2010US20100311744 Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40
12/09/2010US20100311743 Azaindoles Useful as Inhibitors of Janus Kinases
12/09/2010US20100311741 Bicyclosulfonyl Acid (BCSA) Compounds and Their Use as Therapeutic Agents
12/09/2010US20100311736 Pyridosulfonamide derivatives as p13 kinase inhibitors
12/09/2010US20100311732 Novel heterocyclic compounds
12/09/2010US20100311715 Alpha carbolines and uses thereof
12/09/2010US20100311712 Modulators of cxcr7
12/09/2010US20100311709 2-[1-PHENYL-5-HYDROXY OR METHOXY-4ALPHA-METHYL-HEXAHYDROCYCLOPENTA [f]INDAZOLE-5-YL]ETHYL PHENYL DERIVATIVES AS GLUCOCORTICOID RECEPTOR LIGANDS
12/09/2010US20100311706 Method of treatment of allergic rhinitis
12/09/2010US20100311700 Transdermal preparation for external use containing nonsterioidal antiinflammatory/analgesic agent
12/09/2010US20100311666 Cosmetic use of a protein belonging to the ribonuclease family
12/09/2010US20100311661 Use of compounds derived from cycloheximide for the treatment or prevention of, in particular, ischaemias and cardiopathies
12/09/2010US20100311651 Use of glp-1 compound for treatment of critically ill patients
12/09/2010US20100311644 Isozyme-specific antagonists of protein kinase c
12/09/2010US20100311643 Use of glp-1 as a therapeutic agent
12/09/2010US20100311595 Lipophilic drug delivery vehicle and methods of use thereof
12/09/2010US20100311189 Novel Receptor Nucleic Acids and Polypeptides
12/09/2010US20100311120 Human cytokine receptor
12/09/2010US20100311075 Human sodium-dependent bile acid transporter proteins
12/09/2010US20100310684 Methods for treating and preventing mucositis
12/09/2010US20100310673 Substance and composition both capable of imparting heat resistance
12/09/2010US20100310670 Sustained-release microsphere containing short chain deoxyribonucleic acid or short chain ribonucleic acid and method of producing the same
12/09/2010US20100310664 Compositions and methods for treating insulin resistance and diabetes mellitus
12/09/2010US20100310651 Solid pharmaceutical compositions and processes for their production
12/09/2010US20100310576 COMPOSITIONS AND METHODS COMPRISING ASPARTYL-tRNA SYNTHETASES HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES
12/09/2010US20100310564 Method for the Treatment of Glomerulonephritis
12/09/2010US20100310555 Compositions with hematopoietic and immune activity
12/09/2010US20100310549 Inhibitors of type 2 vascular endothelial growth factor receptors
12/09/2010US20100310542 Pharmaceutical Compositions for treating wouds and related methods
12/09/2010US20100310541 Compositions and Methods for Reducing the Toxicity of Certain Toxins
12/09/2010US20100310509 COMPOSITIONS COMPRISING MODULATORS OF SIGNAL TRANSDUCING RECEPTOR gp130 AND METHODS OF PRODUCING AND USING SAME
12/09/2010US20100310508 METHODS OF TREATMENT INVOLVING p21/CIP1
12/09/2010US20100310503 Novel compositions and methods for cancer treatment
12/09/2010US20100310501 Methods for Improving Immune Function and Methods for Prevention or Treatment of Disease in a Mammalian Subject
12/09/2010US20100310498 Active agents and their oligomers and polymers
12/09/2010US20100310471 Antioxidant and paramagnetic heparin-nitroxide derivatives
12/09/2010US20100310470 Immunomodulatory polymeric antigens for treating inflammatory pathologies
12/09/2010US20100310469 Vaccine immunotherapy for immune suppressed patients
12/09/2010US20100310465 Nano-devices having releasable seals for controlled release of molecules
12/09/2010US20100310464 Antibodies
12/09/2010US20100310455 Heterocyclic Ligands for Integrin Imaging and Therapy
12/09/2010DE202008017925U1 Arzneimittel aus Pflanzenrohstoffe zur Kongelationsprävention und Kongelationsbehandlung Drugs derived from plants and raw materials for Kongelationsprävention Kongelationsbehandlung
12/09/2010CA2764461A1 Serum amyloid p derivatives and their preparation and use
12/09/2010CA2764424A1 Vaccine for mycoplasma infection
12/09/2010CA2764296A1 Derivatives of 6,7-dihydro-5h-imidazo[1,2-.alpha.]imidazole-3-carboxylic acid amides
12/09/2010CA2764164A1 Immunoregulatory peptides and methods of use
12/09/2010CA2763977A1 Human milk peptides
12/09/2010CA2763822A1 Naphthalene carboxamide derivatives as inhibitors of protein kinase and histone deacetylase, preparation methods and uses thereof
12/09/2010CA2762307A1 Crystalline forms of 6-(1h-imidazol-1-yl)-2-phenylquinazoline and salts thereof
12/08/2010EP2258834A1 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis
12/08/2010EP2258722A2 Antibodies to fibroblast growth factor-like (FGF-like) polypeptides
12/08/2010EP2258708A1 Macrolide compounds endowed with antiinflammatory activity
12/08/2010EP2258704A1 Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 map kinase
12/08/2010EP2258694A1 Amines as histamine-3 receptor ligands and their therapeutic applications
12/08/2010EP2258689A1 Benzylated PDE4 inhibitors
12/08/2010EP2258688A1 Pyridinone derivatives for treatment of atherosclerosis
12/08/2010EP2258687A1 Nicotinamide derivates useful as P38 inhibitors
12/08/2010EP2258397A1 Polymer conjugate of physiologically active substance
12/08/2010EP2258380A1 Substance and composition both capable of imparting heat resistance
12/08/2010EP2258377A2 Glycerophospholipids containing omega-3 and omega-6 fatty acids
12/08/2010EP2258363A1 Compositions for treatment of cancers
12/08/2010EP2258362A2 Titration dosing regimen for controlled release tramadol
12/08/2010EP2258361A1 Use of benzophenone derivative or salt thereof and tnf inhibitor in combination and pharmaceutical composition containing the derivative or salt thereof and the inhibitor
12/08/2010EP2257568A1 16 alpha, 17 alpa-acetal glucocorticosteroidal derivatives and their use
12/08/2010EP2257546A2 Functionally selective alpha2c adrenoreceptor agonists
12/08/2010EP2257536A2 Cyclic diaryl ether as antagonists of prostaglandin d2 receptors
12/08/2010EP2257527A1 Substituted sulfonamide derivatives
12/08/2010EP2257517A1 Salts of memantine and cox-inhibitors and their crystal form in the treatment of pain
12/08/2010EP2257303A1 Uses of modified elr-cxc chemokine g31p
12/08/2010EP2257282A2 Fatty acid derivatives for use in the prevention and treatment of hsmi
12/08/2010EP1933835B1 Tetrahydro-pyrrolo[1,2-b]isothiazole 1,1-dioxides as lfa-1 inhibitors
12/08/2010EP1578351B1 Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders
12/08/2010EP1553924B1 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system
12/08/2010EP1506285B1 Combinations of anti-dr5 antibodies and anti-dr4 antibodies and other therapeutic agents
12/08/2010EP1322318B1 Use of probiotic lactic acid bacteria for preventing ultraviolet radiation induced inflammatory or allergic reaction or immunosuppression in the skin
12/08/2010EP1093457B1 Cytokine receptor common gamma chain like
12/08/2010EP0772619B2 Immunomodulatory oligonucleotides
12/08/2010CN1977892B Method for regulating baicalin and baicalein ratio in scutellariae root extract
12/08/2010CN1977837B Application of monoesters of probucol for the treatment of cardiovascular and inflammatory disease
12/08/2010CN1803837B Neurotrophic growth factor
12/08/2010CN1709409B Anti-tumor agent, beverages and foods using the same, and a process for manufacturing the anti-tumor agent
12/08/2010CN1698611B Nanometer vauqueline liposome and preparation method thereof
12/08/2010CN1671696B Kinase inhibitors
12/08/2010CN1660184B Combination of medicaiton containing extractive of herb of glabrous sarcandra, and preparation method and application
12/08/2010CN101910176A Derivatives of N-phenyl-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof
12/08/2010CN101910175A N-phenyl-imidazo[1,2-a]pyridine-2-carboxamide compounds, preparation thereof and therapeutic application thereof
12/08/2010CN101910173A Derivatives of 2-heteroaroyl-imidazol[1,2-a] pyridine, preparation thereof and therapeutic application thereof
12/08/2010CN101910172A Derivatives of n-heterocyclic-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof
12/08/2010CN101910171A Nonsteroidal compounds useful as modulators of glucocorticoid receptor AP-1 and/or NF-kappa B activity and use thereof
12/08/2010CN101910169A Bicycloamine derivative
12/08/2010CN101910157A Indole compounds and methods for treating visceral pain
12/08/2010CN101910127A (aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor
12/08/2010CN101910111A Processes for preparing a substituted gamma-amino acid
12/08/2010CN101909653A Composition exhibiting high osmotic antimicrobial, anti-inflammatory and regeneration activity
12/08/2010CN101909651A External preparation composition comprising fatty acid-based ionic liquid as active ingredient
12/08/2010CN101906106A Novel heterocyclic compounds as HSP90-inhibitors
12/08/2010CN101906104A 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
12/08/2010CN101906101A Rotundine crystal B-type solid matter and preparation method as well as applications
1 ... 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 ... 1272